This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Ameritech Biomedicines
product type :
antibody
product name :
Phospho-JNK1/2/3 (T183/Y185) Polyclonal Antibody
catalog :
ATB-P0157
quantity :
100 ug
price :
238 USD
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
reactivity :
human, mouse, rat
application :
western blot, ELISA
product information
catalog no :
ATB-P0157
product name :
Phospho-JNK1/2/3 (T183/Y185) Polyclonal Antibody
Antigen Modification :
phosphorylated
Size :
100 ug
price :
238 USD
product type :
Antibody
small classname :
Kinases and Phosphatases
ISOTYPE :
IGg
Reactivity :
Human,Mouse,Rat
Applications :
WB,ELISA
Gene name :
MAPK8/9/10
Protein name :
Mitogen-activated protein kinase 8/9/10
Human gene id :
5599/5601/5602
Human swiss prot no :
P45983/P45984/P53779
Mouse gene id :
26419/26420
Mouse swiss prot no :
Q91Y86/Q9WTU6/Q61831
Rat gene id :
116554/50658/25272
Rat swiss prot no :
P49185/P49186/P49187
Immunogen :
Synthesized peptide derived from human JNK1/2/3 around the phosphorylation site of T183/Y185.
Specificity :
Phospho-JNK1/2/3 (T183/Y185) Polyclonal Antibody detects endogenous levels of JNK1/2/3 protein only when phosphorylated at T183/Y185.
Formulation :
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Source :
Rabbit
Dilution :
Western Blot: 1/500 - 1/2000. ELISA: 1/10000. Not yet tested in other applications.
Purification :
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration :
1 mg/ml
Storage stability :
-20°C/1 year
cell pathway :
Toll-Like Receptor; Cell Growth; Stem Cell; Insulin Receptor; MAPK; ErbB/HER; B Cell Receptor; SAPK/JNK; Wnt/β-Catenin
company information
Ameritech Biomedicines
13827 Viewfield Ct
Houston, TX 77059
Houston, TX 77059
order@amtbiomed.com
http://www.amtbiomed.com713-987-8466
headquarters: US
questions and comments